Serum concentrations and pharmacokinetics of moxifloxacin in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass
Authors:
- Gunther WiesnerGWGunther Wiesner
- Klaus MartinKMKlaus Martin
- Ralph GertlerRGRalph Gertler
- Siegmund-Lorenz BraunSBSiegmund-Lorenz Braun
- Peter TassaniPTPeter Tassani
- Rüdiger LangeRLRüdiger Lange
- Michael GruberMGMichael Gruber
- 1 May 2013
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 41 (5) , 473-476
Abstract
No abstract availableKeywords
Funding Information
- Bayer Vital GmbH (Leverkusen, Germany)
- Kommission für Klinische Forschung of the Faculty of Medicine, Technical University of Munich (Munich, Germany)
This publication has 11 references indexed in Scilit:
- Penetration of moxifloxacin into liver tissueInternational Journal of Antimicrobial Agents, 2012
- Antibiotic prophylaxis for cardiac surgery.Journal of Antimicrobial Chemotherapy, 2011
- Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2011
- Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patientsJournal of Antimicrobial Chemotherapy, 2011
- 10 years’ experience with the pneumococcal quinolone moxifloxacinExpert Review of Anti-infective Therapy, 2009
- The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part II: Antibiotic ChoiceThe Annals of Thoracic Surgery, 2007
- Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitroJournal of Antimicrobial Chemotherapy, 2005
- The Influence of Age and Gender on the Pharmacokinetics of MoxifloxacinClinical Pharmacokinetics, 2001
- Pharmacokinetics and Inflammatory-Fluid Penetration of Moxifloxacin following Oral or Intravenous AdministrationAntimicrobial Agents and Chemotherapy, 1999
- Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in manJournal of Antimicrobial Chemotherapy, 1999